• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Accord Healthcare`s Degarelix Accord (degarelix) Receives Approval in Europe

    EMA

    UCLA researchers to study prostate cancer drug for Covid-19

    CLINICALTRIALSARENA

    FDA Confirms Paragraph IV Patent Challenge of Firmagon 22201 (Degarelix Acetate 80 mg/vial and 120 mg/vial)Powder for Injection

    FDA

    Myovant`s oral prostate cancer drug matches incumbent in phase 3

    FIERCE BIOTECH

    Myovant`s oral prostate cancer drug matches incumbent in phase 3

    FIERCE BIOTECH

    Myovant`s oral prostate cancer drug matches incumbent in phase 3

    FIERCE BIOTECH

    Ferring pits prostate cancer drug against AbbVie`s Lupron in PhIIIb CV outcomes

    FIERCE BIOTECH

    NICE backs Bayer`s Xofigo but rejects Ferring`s Firmagon

    PHARMA TIMES

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.